178 related articles for article (PubMed ID: 23359392)
1. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
[TBL] [Abstract][Full Text] [Related]
3. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
4. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
5. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA
Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025
[TBL] [Abstract][Full Text] [Related]
6. Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression.
Samarakoon R; Chitnis SS; Higgins SP; Higgins CE; Krepinsky JC; Higgins PJ
PLoS One; 2011; 6(7):e22896. PubMed ID: 21829547
[TBL] [Abstract][Full Text] [Related]
7. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
Song H; Guo B; Zhang J; Song C
Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702
[TBL] [Abstract][Full Text] [Related]
10. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
11. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the transforming growth factor-β pathway by tolfenamic acid via the ERK MAP kinase pathway.
Zhang X; Min KW; Liggett J; Baek SJ
Carcinogenesis; 2013 Dec; 34(12):2900-7. PubMed ID: 23864386
[TBL] [Abstract][Full Text] [Related]
16. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
18. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts.
Kobayashi T; Liu X; Wen FQ; Fang Q; Abe S; Wang XQ; Hashimoto M; Shen L; Kawasaki S; Kim HJ; Kohyama T; Rennard SI
Biochem Biophys Res Commun; 2005 Feb; 327(2):393-8. PubMed ID: 15629128
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.
Ungefroren H; Groth S; Sebens S; Lehnert H; Gieseler F; Fändrich F
Mol Cancer; 2011 May; 10():67. PubMed ID: 21624123
[TBL] [Abstract][Full Text] [Related]
20. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1.
Ren M; Wang B; Zhang J; Liu P; Lv Y; Liu G; Jiang H; Liu F
Mol Med Rep; 2011; 4(3):561-7. PubMed ID: 21468608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
